Press release
Lung Cancer Diagnostics Market ,2018-2028 by Segmentation Based on Product, Application and Region
Fact.MR, in its recent report, estimates the global lung cancer diagnostics market to register an impressive 7.3% CAGR during the forecast period 2017 to 2022.The growth of the global market for lung cancer diagnostics is primarily attributed to increasing developments in lung cancer-specific biomarkers. These diagnostic tools are expected to facilitate personalized treatment approach towards lung malignancies. A number of biomarkers exist in the research pipeline. In the recent past, Epigenomics AG launched a new test based on blood utilizing DNA methylation biomarkers, whose developments are in the process. The initial results obtained from these tests have promised early diagnosis of lung cancer. Such incidences are expected to increase demand for lung cancer diagnostics across the globe.
Competition Tracking
Novel product launches for lung cancer diagnostics is a key strategy adopted by leading players in the global market, in order to increase their product portfolio. Fact.MR’s report profiles key market players, which include Illumina, Inc., Abbott Laboratories, Thermo Fischer Scientific, Inc., QIAGEN N.V., Quest Diagnostics Incorporated, NeoGenomics Laboratories, Inc., NanoString Technologies, Inc., Myriad Genetics, Inc., Roche Holding AG, and Danaher Corporation.
Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=49
Increasing Awareness Programs for Lung Cancer to Drive Growth of the Market
A number of awareness programs associated with lung cancer and its related symptoms have been initiated in order to enhance the diagnosis and screening rates of individuals with high risks of developing lung malignancies. For example – In the United Kingdom, November is considered to be the lung cancer awareness month, and is supported by Roy Castle Lung Cancer Foundation. Such initiatives help in raising awareness about early detection and diagnosis of lung cancer.
CA tests will continue to be the most lucrative tests for lung cancer diagnostics in the market. Revenue from CA tests will account for US$ 889.3 Mn by 2022-end. Angiogenesis inhibitor is expected to witness the fastest expansion among test type in the market, followed by HER 2 tests. Revenue from ALK tests for lung cancer diagnostics will continue to remain low in the market.
Request/View Toc@ https://www.factmr.com/connectus/sample?flag=T&rep_id=49
Hospital-associated Labs to Remain the Most Lucrative End-Users of Lung Cancer Diagnostics
Hospital-associated labs will remain the most lucrative end-users of lung cancer diagnostics in the global market, with revenues estimated to reach nearly US$ 1,500 Mn by 2022-end. Cancer research institutes will continue to exhibit the fastest expansion in the global lung cancer diagnostics market, followed by independent diagnostic laboratories. In addition, independent diagnostic laboratories are expected to be the second largest end-users of lung cancer diagnostics throughout the forecast period.
On the basis of indication, although non-small cell lung cancer is expected to remain sought-after in the market, small cell-lung cancer is expected to exhibit the fastest expansion through 2022. Revenue from non-small cell lung cancer is expected to remain largest during the forecast period. In contrast, revenue from small cell lung cancer will continue to be low in the global lung cancer diagnostics market.
Speak To Research Analyst for Detailed Insights @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=49
Table of COntents Covered in the report are:
Chapter 1. Global Lung Cancer Diagnostics Market - Executive Summary. 12
Chapter 2. Global Lung Cancer Diagnostics Market Overview. 14
2.1. Introduction. 14
2.1.1. Global Lung Cancer Diagnostics Market Taxonomy. 14
2.1.2. Global Lung Cancer Diagnostics Market Definition. 14
2.2. Global Lung Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2012-2022. 15
2.2.1. Global Lung Cancer Diagnostics Market Y-o-Y Growth. 15
2.3. Global Lung Cancer Diagnostics Market Dynamics. 15
2.3.1. Drivers. 15
2.3.2. Restraints. 15
2.3.3. Trends. 16
2.4. Supply Chain. 16
2.5. Key Participants Market Presence (Intensity Map) By Region. 16
Access This Report @ https://www.factmr.com/checkout/49/S
Chapter 3. Global Lung Cancer Diagnostics Market Analysis and Forecast By Test Type. 17
3.1. Global Lung Cancer Diagnostics Market Size and Forecast By Test Type, 2012-2022. 17
3.1.1. CA Test Lung Cancer Diagnostics Market Size and Forecast, 2012-2022. 17
3.1.1.1. Revenue (US$ Mn) Comparison, By Region. 17
3.1.1.2. Market Share Comparison, By Region. 19
3.1.1.3. Y-o-Y growth Comparison, By Region. 19
3.1.2. HER2 Tests Lung Cancer Diagnostics Market Size and Forecast, 2012-2022. 20
3.1.2.1. Revenue (US$ Mn) Comparison, By Region. 20
3.1.2.2. Market Share Comparison, By Region. 22
3.1.2.3. Y-o-Y growth Comparison, By Region. 22
3.1.3. ALK Tests Lung Cancer Diagnostics Market Size and Forecast, 2012-2022. 23
3.1.3.1. Revenue (US$ Mn) Comparison, By Region. 23
3.1.3.2. Market Share Comparison, By Region. 25
3.1.3.3. Y-o-Y growth Comparison, By Region. 25
3.1.4. Angiogenesis Inhibitor Lung Cancer Diagnostics Market Size and Forecast, 2012-2022. 26
3.1.4.1. Revenue (US$ Mn) Comparison, By Region. 26
3.1.4.2. Market Share Comparison, By Region. 28
3.1.4.3. Y-o-Y growth Comparison, By Region. 28
3.1.5. EGFR Mutation Tests Lung Cancer Diagnostics Market Size and Forecast, 2012-2022. 29
3.1.5.1. Revenue (US$ Mn) Comparison, By Region. 29
3.1.5.2. Market Share Comparison, By Region. 31
3.1.5.3. Y-o-Y growth Comparison, By Region. 31
3.1.6. KRAS Mutation Tests Lung Cancer Diagnostics Market Size and Forecast, 2012-2022. 32
3.1.6.1. Revenue (US$ Mn) Comparison, By Region. 32
3.1.6.2. Market Share Comparison, By Region. 34
3.1.6.3. Y-o-Y growth Comparison, By Region. 34
3.1.7. Others Lung Cancer Diagnostics Market Size and Forecast, 2012-2022. 35
3.1.7.1. Revenue (US$ Mn) Comparison, By Region. 35
3.1.7.2. Market Share Comparison, By Region. 37
3.1.7.3. Y-o-Y growth Comparison, By Region. 37
Chapter 4. Global Lung Cancer Diagnostics Market Analysis and Forecast By End User. 39
4.1. Global Lung Cancer Diagnostics Market Size and Forecast By End User, 2012-2022. 39
4.1.1. Hospital Associated Labs Lung Cancer Diagnostics Market Size and Forecast, 2012-2022. 39
4.1.1.1. Revenue (US$ Mn) Comparison, By Region. 39
4.1.1.2. Market Share Comparison, By Region. 41
4.1.1.3. Y-o-Y growth Comparison, By Region. 41
4.1.2. Independent Diagnostic Laboratories Lung Cancer Diagnostics Market Size and Forecast, 2012-2022. 42
4.1.2.1. Revenue (US$ Mn) Comparison, By Region. 42
4.1.2.2. Market Share Comparison, By Region. 44
4.1.2.3. Y-o-Y growth Comparison, By Region. 44
4.1.3. Cancer Research Institutes Lung Cancer Diagnostics Market Size and Forecast, 2012-2022. 45
4.1.3.1. Revenue (US$ Mn) Comparison, By Region. 45
4.1.3.2. Market Share Comparison, By Region. 47
4.1.3.3. Y-o-Y growth Comparison, By Region. 47
4.1.4. Others Lung Cancer Diagnostics Market Size and Forecast, 2012-2022. 48
4.1.4.1. Revenue (US$ Mn) Comparison, By Region. 48
4.1.4.2. Market Share Comparison, By Region. 50
4.1.4.3. Y-o-Y growth Comparison, By Region. 50
Chapter 5. Global Lung Cancer Diagnostics Market Analysis and Forecast By Indication. 52
5.1. Global Lung Cancer Diagnostics Market Size and Forecast By Indication, 2012-2022. 52
5.1.1. Non Small-cell Lung Cancer Lung Cancer Diagnostics Market Size and Forecast, 2012-2022. 52
5.1.1.1. Revenue (US$ Mn) Comparison, By Region. 52
5.1.1.2. Market Share Comparison, By Region. 54
5.1.1.3. Y-o-Y growth Comparison, By Region. 54
5.1.2. Small-cell Lung Cancer Lung Cancer Diagnostics Market Size and Forecast, 2012-2022. 55
5.1.2.1. Revenue (US$ Mn) Comparison, By Region. 55
5.1.2.2. Market Share Comparison, By Region. 57
5.1.2.3. Y-o-Y growth Comparison, By Region. 57
Chapter 6. Global Lung Cancer Diagnostics Market Analysis and Forecast By Region. 59
6.1. Global Lung Cancer Diagnostics Market Size and Forecast, 2012-2022. 59
6.1.1. North America Lung Cancer Diagnostics Market Size and Forecast, 2012-2022. 59
6.1.1.1. Revenue (US$ Mn) Comparison, By Test Type. 59
6.1.1.2. Revenue (US$ Mn) Comparison, By End User. 61
6.1.1.3. Revenue (US$ Mn) Comparison, By Indication. 62
6.1.2. Latin America Lung Cancer Diagnostics Market Size and Forecast, 2012-2022. 64
6.1.2.1. Revenue (US$ Mn) Comparison, By Test Type. 64
6.1.2.2. Revenue (US$ Mn) Comparison, By Indication. 67
6.1.3. Europe Lung Cancer Diagnostics Market Size and Forecast, 2012-2022. 69
6.1.3.1. Revenue (US$ Mn) Comparison, By Test Type. 69
6.1.3.2. Revenue (US$ Mn) Comparison, By End User. 71
6.1.3.3. Revenue (US$ Mn) Comparison, By Indication. 72
6.1.4. Japan Lung Cancer Diagnostics Market Size and Forecast, 2012-2022. 74
6.1.4.1. Revenue (US$ Mn) Comparison, By Test Type. 74
6.1.4.2. Revenue (US$ Mn) Comparison, By Indication. 77
6.1.5. APEJ Lung Cancer Diagnostics Market Size and Forecast, 2012-2022. 79
6.1.5.1. Revenue (US$ Mn) Comparison, By Test Type. 79
6.1.5.2. Revenue (US$ Mn) Comparison, By End User. 81
6.1.5.3. Revenue (US$ Mn) Comparison, By Indication. 82
6.1.6. MEA Lung Cancer Diagnostics Market Size and Forecast, 2012-2022. 84
6.1.6.1. Revenue (US$ Mn) Comparison, By Test Type. 84
6.1.6.2. Revenue (US$ Mn) Comparison, By End User. 86
6.1.6.3. Revenue (US$ Mn) Comparison, By Indication. 87
Chapter 7. North America Lung Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022. 90
7.1. US Lung Cancer Diagnostics Market Size and Forecast, 2012-2022. 90
7.1.1. Revenue (US$ Mn) Comparison, By Test Type. 90
7.1.2. Revenue (US$ Mn) Comparison, By End User. 91
7.1.3. Revenue (US$ Mn) Comparison, By Indication. 91
7.2. Canada Lung Cancer Diagnostics Market Size and Forecast, 2012-2022. 92
7.2.1. Revenue (US$ Mn) Comparison, By Test Type. 92
7.2.2. Revenue (US$ Mn) Comparison, By End User. 93
7.2.3. Revenue (US$ Mn) Comparison, By Indication. 94
Chapter 8. Latin America Lung Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022. 96
8.1. Brazil Lung Cancer Diagnostics Market Size and Forecast, 2012-2022. 96
8.1.1. Revenue (US$ Mn) Comparison, By Test Type. 96
8.1.2. Revenue (US$ Mn) Comparison, By End User. 97
8.1.3. Revenue (US$ Mn) Comparison, By Indication. 97
8.2. Mexico Lung Cancer Diagnostics Market Size and Forecast, 2012-2022. 98
8.2.1. Revenue (US$ Mn) Comparison, By Test Type. 98
8.2.2. Revenue (US$ Mn) Comparison, By End User. 99
8.2.3. Revenue (US$ Mn) Comparison, By Indication. 100
8.3. Argentina Lung Cancer Diagnostics Market Size and Forecast, 2012-2022. 101
8.3.1. Revenue (US$ Mn) Comparison, By Test Type. 101
8.3.2. Revenue (US$ Mn) Comparison, By End User. 102
8.3.3. Revenue (US$ Mn) Comparison, By Indication. 103
And Continue...
About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Follow Us on Linkedin: www.linkedin.com/company/factmr/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lung Cancer Diagnostics Market ,2018-2028 by Segmentation Based on Product, Application and Region here
News-ID: 1583921 • Views: …
More Releases from Fact.MR

Insulated Drinkware Market to Hit USD 2.57 Billion by 2033 | YETI, Thermos L.L.C …
The global insulated drinkware market was valued at US$ 1.39 billion in 2023 and is forecasted to expand at a 6.3% CAGR over the next ten years. Worldwide sales of insulated drinkware are projected to reach US$ 2.57 billion by 2033-end.This robust growth is driven by increasing consumer awareness of sustainability, rising participation in outdoor activities, and the growing demand for reusable, eco-friendly products amid bans on single-use plastics.
The market…

Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB L …
Digital Twin Market is valued at USD 5 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 34.3%, reaching USD 95 billion by 2033. This explosive growth is driven by the increasing adoption of digital twins across industries to optimize operations, reduce costs, and enhance decision-making through virtual replicas of physical assets. Digital twins integrate IoT, AI, and data analytics to simulate real-world…

Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 …
The global hemato oncology testing market is valued at USD 4.33 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 18.5%, reaching USD 23.64 billion by 2033. This rapid growth is driven by the increasing prevalence of blood-related cancers, such as lymphoma and leukemia, and advancements in diagnostic technologies like next-generation sequencing (NGS) and polymerase chain reaction (PCR). Hemato oncology testing plays a…

Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 203 …
Osseointegration Implants Market is poised for robust growth, with its valuation projected to rise from USD 3.17 billion in 2025 to USD 6.85 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8%. This expansion is driven by the increasing prevalence of orthopedic and dental disorders, such as osteoarthritis, rheumatoid arthritis, and edentulism, which necessitate advanced implant solutions. Osseointegration implants, which fuse directly with bone to provide stable…
More Releases for Comparison
STM32F vs STM32G: A Comprehensive Comparison
When it comes to embedded systems development, selecting the right microcontroller (MCU) can significantly impact the performance, power consumption, and cost-effectiveness of your project. STM32F vs STM32G ( https://www.chipmall.com/blogs/stm32f-vs-stm32g_92 ) is a common comparison in the embedded community, as both series from STMicroelectronics offer powerful solutions, but they serve different needs and use cases. The STM32F and STM32G families, both based on ARM Cortex-M cores, provide developers with a wide…
A11VO Hydraulic Pump Price Comparison Guide
The A11VO Hydraulic Pump exhibits significant price differences across various suppliers. These variations arise from factors like manufacturing costs, supplier markups, and geographic location. Understanding these differences proves crucial for buyers. It enables them to make informed decisions and secure the best deals. By comparing prices, buyers can identify the most cost-effective options without compromising on quality. This knowledge empowers them to navigate the market efficiently and optimize their investment…
Moneybrag.com Offers Reliable Financial Comparison Services
Moneybrag.com is a leading online firm that specializes in online comparison services that enable clients to make comparisons of utility and personal finance products. Their primary goal is to provide information in an understandable format that allows for initial comparisons to be made at a glance. This enables customers to make healthy financial decisions. Moneybrag.com gives customers the ability to compare side by side and select a vendor based on…
Comparison of Time recording applications
With hiring remote staff and freelancers halfway around the world turning into further common, it is necessary to look out the only thanks to keep track of the hours they work. Not entirely are you able to would like to know the hours to be able to pay them at the tip of the month but together notice an easy due to manage the invoices of an entire team. If…
EInsuranceEz.com Launches Health Insurance Comparison Portal
EInsuranceEz.com, the online insurance price comparison company, launched a brand new customer-focused website this month. The site, einsuranceez.com, is designed to offer customers a wide range of competitively-priced life insurance, health insurance and auto insurance quotes instantly online.
Working with some of the US biggest providers, EInsuranceEz.com constantly compares the best deals and insurance rates on the market to ensure that the customer gets the greatest saving for them.
The company VP…
PriceForSure.com - Benefits of Comparison Shopping
Comparison Shopping websites are beneficial to consumers and merchants because they offer a number of benefits.
( EMAILWIRE.COM, June 20, 2007 ) Rincon, Georgia – PriceForSure.com (www.PriceForSure.com) announces the benefits of comparison shopping. This informative and often entertaining form of shopping makes it easier for consumers to find the best deals on the web. Consumers search for products that they are interested in by comparing product types, product features,…